Co-enzyme Q10 supplementation for the primary prevention of cardiovascular disease

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 12, 2014, Pages

  Flowers, Nadine ^a   Hartley, Louise ^a   Todkill, Daniel ^a   Stranges, Saverio ^a   Rees, Karen ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UBIDECARENONE; ANTIOXIDANT; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; UBIQUINONE;

ADULT; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; ANALOGS AND DERIVATIVES; BLOOD; CARDIOVASCULAR DISEASES; META ANALYSIS; PROCEDURES;

ANTIOXIDANTS; CARDIOVASCULAR DISEASES; CHOLESTEROL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPIDS; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; UBIQUINONE;

EID: 84925226700     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD010405.pub2     Document Type: Review

References (82)

1. Bargossi AM, Grossi G, Fiorella PL, Gaddi A, Di Giuliol R, Battino M. Exogenous CoQ10 supplementation prevents plasma ubiquinone reduction induced by HMG-CoA reductase inhibitors. Molecular Aspects of Medicine 1994;15 Suppl:s187-93.
2. Kaikkonen J, Nyyssonen K, Tomasi A, Iannone A, Tuomainen TP, Porkkala-Sarataho E, et al. Antioxidative efficacy of parallel and combined supplementation with coenzyme Q10 and d-α-tocopherol in mildly hypercholesterolemic subjects: a randomised placebo-controlled clinical study. Free Radical Research 2000;33:329-40.
3. Lee YJ, Cho WJ, Kim JK, Lee DC. Effects of coenzyme Q10 on arterial stiffness, metabolic parameters, and fatigue in obese subjects: a double-blind randomised controlled study. Journal of Medicinal Food 2011;14(4):386-90.
4. Mabuchi H, Nohara A, Kobayashi J, Kawashiri M, Katsuda S, Inazu A, et al. Effects of CoQ10 supplementation on plasma lipoprotein lipid, CoQ10 and liver and muscle enzyme levels in hypercholesterolemic patients treated with atorvastatin: a randomized double-blind study. Atherosclerosis 2007;195:e182-9.
5. Yamagami T, Takagi M, Akagami H, Kubo H, Toyama S, Okamoto T, et al. Effect of coenzyme Q10 on essential hypertension, a double blind controlled study. Biomedical and Clinical Aspects of Coenzyme Q10: Proceedings of the Fifth International Symposium on the Biomedical and Clinical Aspects of Coenzyme Q10. 1986; Vol. 5:337-43.
6. Young JM, Florkowski CM, Molyneux SL, McEwan RG, Frampton CM, Georgeb PM, et al. Effect of coenzyme Q10 supplementation on simvastatin-induced myalgia. American Journal of Cardiology 2007;100:1400-3.
7. Bonetti A, Solito F, Carmosino G, Bargossi AM, Fiorella PL. Effect of ubidecarenone oral treatment on aerobic power in middle-aged trained subjects. Journal of Sports Medicine & Physical Fitness 2000;40(1):51-7.
8. Bookstaver DA, Burkhalter NA, Hatzigeorgiou C. Effect of coenzyme Q10 supplementation on statin-induced myalgias. American Journal of Cardiology 2012;110(4):526-9.
9. Burke BE, Neuenschwander R, Olson RD. Randomized, double-blind, placebo-controlled trial of coenzyme Q10 in isolated systolic hypertension. Southern Medical Journal 2001;94(11):1112-7.
10. Caso G, Kelly P, McNurlan MA, Lawson WE. Effect of coenzyme q10 on myopathic symptoms in patients treated with statins. American Journal of Cardiology 2007;99(10):1409-12.
11. Cooke M, Iosia M, Buford T, Shelmadine B, Hudson G, Kerksick C, et al. Effects of acute and 14-day coenzyme Q10 supplementation on exercise performance in both trained and untrained individuals. Journal of the International Society of Sports Nutrition 2008;5:8.
12. Delgado-Casado N, Yubero-Serrano EM, Perez-Martinez P, Tasset-Cuevas I, Santos-Gonzalez M, Delgado-Lista J, et al. The supplementation of coenzyme Q10 to a Mediterranean diet improves antioxidant systems and reduces cellular oxidation in elderly subjects. Atherosclerosis Supplements 2010;11(2):91.
13. Digiesi V, Cantini F, Brodbeck B. Effect of coenzyme Q10 on essential arterial hypertension. Current Therapeutic Research - Clinical and Experimental 1990;47(5):841-5.
14. Gokbel H, Gergerlioglu HS, Okudan N, Gul I, Buyukbas S, Belviranli M. Effects of coenzyme Q10 supplementation on plasma adiponectin, interleukin-6, and tumor necrosis factor-alpha levels in men. Journal of Medicinal Food 2010;13(1):216-8.
15. Gul I, Gokbel H, Belviranli M, Okudan N, Buyukbas S, Basarali K. Oxidative stress and antioxidant defense in plasma after repeated bouts of supramaximal exercise: the effect of coenzyme Q10. Journal of Sports Medicine and Physical Fitness 2011;51(2):305-12.
16. Kaikkonen J, Nyyssonen K, Porkkala-Sarataho E, Poulsen HE, Metsa-Ketela T, Hayn M, et al. Effect of oral coenzyme q10 supplementation on the oxidation resistance of human VLDL+LDL fraction: absorption and antioxidative properties of oil and granule-based preparations. Free Radical Biology and Medicine 1997;22(7):1195-202.
17. Kelly P, Vasu S, Getato M, McNurlan M, Lawson WE. Coenzyme Q10 improves myopathic pain in statin treated patients (abstract). Journal of the American College of Cardiology 2005;45:3A.
18. Kuettner A, Pieper A, Koch J, Enzmann F, Schroeder S. Influence of coenzyme Q10 and cerivastatin on the flow-mediated vasodilation of the brachial artery: results of the ENDOTACT study. International Journal of Cardiology 2005;98(3):413-9.
19. Malm C, Svensson M, Ekblom B, Sjodin B. Effects of ubiquinone-10 supplementation and high intensity training on physical performance in humans. Acta Physiologica Scandinavica 1997;161(3):379-84.
20. Nuku K, Matsuoka Y, Yamagishi T, Miyawaki H, Sato K. Safety assessment of PureSorb-Q40 in healthy subjects and serum coenzyme Q10 level in excessive dosing. Journal of Nutritional Science & Vitaminology 2007;53(3):198-206.
21. Nukui K, Yamagishi T, Miyawaki H, Kettawan A, Okamoto T, Belardinelli R, et al. Blood CoQ10 levels and safety profile after single-dose or chronic administration of PureSorb-Q40: animal and human studies. BioFactors 2008;32(1-4):209-19.
22. Ostman B, Sjodin A, Michaelsson K, Byberg L. Coenzyme Q10 supplementation and exercise-induced oxidative stress in humans. Nutrition 2012;28(4):403-17.
23. Raitakari OT, McCredie RJ, Witting P, Griffiths KA, Letters J, Sullivan D, et al. Coenzyme Q improves LDL resistance to ex vivo oxidation but does not enhance endothelial function in hypercholesterolemic young adults. Free Radical Biology & Medicine 2000;28(7):1100-5.
24. Shah SA, Sander S, Cios D, Lipeika J, Kluger J, White CM. Electrocardiographic and hemodynamic effects of coenzyme Q10 in healthy individuals: a double-blind, randomized controlled trial. Annals of Pharmacotherapy 2007;41(3):420-5.
25. Shojaei M, Djalali M, Khatami M, Siassi F, Eshraghian M. Effects of carnitine and coenzyme Q10 on lipid profile and serum levels of lipoprotein(a) in maintenance hemodialysis patients on statin therapy. Iranian Journal of Kidney Diseases 2011;5(2):114-8.
26. Svensson M, Malm C, Tonkonogi M, Ekblom B, Sjodin B, Sahlin K. Effect of Q10 supplementation on tissue Q10 levels and adenine nucleotide catabolism during high-intensity exercise. International Journal of Sport Nutrition 1999;9(2):166-80.
27. Weston SB, Zhou S, Weatherby RP, Robson SJ. Does exogenous coenzyme Q10 affect aerobic capacity in endurance athletes?. International Journal of Sport Nutrition 1997;7(3):197-206.
28. Ylikoski T, Piirainen J, Hanninen O, Penttinen J. The effect of coenzyme Q10 on the exercise performance of cross-country skiers. Molecular Aspects of Medicine 1997;18 Suppl:s283-90.
29. Young JM, Florkowski CM, Molyneux SL, McEwan RG, Frampton CM, Nicholls MG, et al. A randomized, double-blind, placebo-controlled crossover study of coenzyme Q10 therapy in hypertensive patients with the metabolic syndrome. American Journal of Hypertension 2012;25(2):261-70.
30. Zheng A, Moritani T. Influence of CoQ10 on autonomic nervous activity and energy metabolism during exercise in healthy subjects. Journal of Nutritional Science & Vitaminology 2008;54(4):286-90.
31. Zita C, Overvad K, Mortensen SA, Sindberg CD, Moesgaard S, Hunter DA. Serum coenzyme Q(10) concentrations in healthy men supplemented with 30 mg or 100 mg coenzyme Q(10) for two months in a randomised controlled study. BioFactors 2003;18(1-4):185-93.
32. Fedacko J, Pella D, Fedackova P, Hänninen O, Tuomainen P, Jarcuska P, et al. Coenzyme Q10 and selenium in statin-associated myopathy treatment. Canadian Journal of Physiology and Pharmacology 2013;91:165-70.
33. Fedacko J, Pella D, Rybar R, Fedackova P, Dudova D. Coenzyme Q10 and selenium in statin-associated myopathy treatment. Results of randomized double-blind clinical study. European Heart Journal 2009;30:234.
34. Fedacko J, Pella D, Rybar R, Fedackova P, Jarcuska P, Vargova V. Influence of Coenzyme Q10 on left ventricular diastolic function in statin treated patients. 14th World Congress on Clinical Nutrition and 5th International Congress on Cardiovascular Diseases. 40128 Bologna: Medimond S R L, 2009.
35. Fedacko J, Pella D, Rybar R, Fedackova P, Mechirova V. Coenzyme Q10 and selenium supplementation in patients with statin-associated myopathy. Atherosclerosis Supplements 2009;10:2.
36. Fedacko J, Pella D, Rybar R, Lopuchovsky T, Tuomainen P, Merkovska L, et al. The role of selenium supplementation on top of coenzyme Q10 in statins treated patients with possible diastolic dysfunction of left ventricular. European Heart Journal 2012;33:613.
37. Golomb BA. Q10 for Gulf War Veterans (GULF). NCT01011348: http://clinicaltrials.gov/show/NCT01011348(accessed 22 July 2013).
38. Molyneux S. A double-blind, randomised, placebo controlled, 12-week cross-over study to assess the effect of Coenzyme Q10 treatment on 24hr mean ambulatory systolic and diastolic blood pressure in inadequately treated hypertensive patients with the metabolic syndrome. ACTRN12611000241932: http://apps.who.int/trialsearch/trial.aspx?trialid=ACTRN12611000241932 (accessed 22 July 2013).
39. Mozaffari H, Mohammadi Zarchi SM. The study of coenzyme Q10 supplementation on blood pressure, inflammation factors and adiponectin in hypertensive patients. IRCT201103086002N1: http://apps.who.int/trialsearch/trial.aspx?trialid=IRCT201103086002N1 (accessed 22 July 2013).
40. Usefzadeh G, Najarzadeh A. Effect of coenzyme Q10 Supplementation on Metabolic Syndrome Parameters, lipid peroxidation, hs-CRP and homocysteine in patients with metabolic syndrome. IRCT2012101311092N2: http://apps.who.int/trialsearch/trial.aspx?trialid=IRCT2012101311092N2 (accessed 22 July 2013).
41. Young J. Randomised, double blind, placebo controlled, cross over study to investigate the effect of dietary supplementation with coenzyme Q10 on endothelial function in males with the metabolic syndrome who are concurrently on statin treatment. ACTRN12609000232235: http://apps.who.int/trialsearch/trial.aspx?trialid=ACTRN12609000232235 (accessed 22 July 2013).
42. Alehagen U, Johansson P, Björnstedt M, Rosén A, Dahlström U. Cardiovascular mortality and N-terminal-proBNP reduced after combined selenium and coenzyme Q10 supplementation: a 5-year prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens. International Journal of Cardiology 2013;167:1860-6.
43. Begg S, Vos T, Barker B, Stevenson C, Stanley L, Lopez A. The Burden of Disease and Injury in Australia 2003. Canberra: Australian Institute of Health and Welfare, 2007. [: Cat. no. PHE 82]
44. British Heart Foundation. Cardiovascular Disease. 2012. http://www.bhf.org.uk/heart-health/conditions/cardiovascular-disease.aspx (accessed April 2012).
45. Caso G, Kelly P, McNurlan MA, Lawson WE. Effect of coenzyme q10 on myopathic symptoms in patients treated with statins. American Journal of Cardiology 2007;99(10):1409-12.
46. Folkers K, Langsjoen P, Willis R, Richardson P, Xia LJ, Ye CQ, et al. Lovastatin decreases coenzyme Q levels in humans. Proceedings of the National Academy of Sciences of the United States of America 1990;87:8931-4.
47. Gao L, Mao Q, Cao J, Wang Y, Zhou X, Fan L. Effects of coenzyme Q10 on vascular endothelial function in humans: a meta-analysis of randomized controlled trials. Atherosclerosis 2012;221(2):311-6.
48. He F, Burnier M, MacGregor G. Nutrition in cardiovascular disease: salt in hypertension and heart failure. European Heart Journal 2011;32:3073-80.
49. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
50. Ho MJ, Bellusci A, Wright JM. Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD007435.pub2]
51. Hofman-Bang C, Rehnquist N, Swedberg K, Wiklund I, Astrom H. Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart failure. The Q10 study group. Journal of Cardiac Failure 1995;1:101-7.
52. Ignarro LJ. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circulation Research 1989;65:1-21.
53. Kato T, Yoneda S. Reduction in blood viscosity by treatment with coenzyme Q10 in patients with ischemic heart disease. International Journal of Clinical Pharmacology, Therapy and Toxicology 1990;28(3):123-6.
54. Kendler BS. Supplemental conditionally essential nutrients in cardiovascular disease therapy. Journal of Cardiovascular Nursing 2006;21(1):9-16.
55. Kumar A, Kaur H, Devi P, Mohan V. Role of coenzyme Q10 (CoQ10) in cardiac disease, hypertension and Meniere-like syndrome. Pharmacology and Therapeutics 2009;124(3):259-68.
56. Langsjoen PH, Vadhanavikit S, Folkers K. Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme Q10. Proceedings of the National Academy of Sciences of the United States of America 1985;82:4240-4.
57. Langsjoen PH. A six-year clinical study of therapy of cardiomyopathy with coenzyme Q10. International Journal of Tissue Reactions 1990;12(3):169-71.
58. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011], The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
59. Littarru GP, Ho L, Folkers K. Deficiency of coenzyme Q10 in human heart disease. Part I. International Journal for Vitamin and Nutrition Research 1972;42:291-305.
60. Mackay J, Manesh GA. The Atlas of Heart Disease and Stroke. Geneva: World Health Organization, 2004.
61. McCarty MF. Coenzyme Q versus hypertension: does CoQ decrease endothelial superoxide generation?. Medical Hypotheses 1999;53(4):300-4.
62. Mohr D, Bowry VW, Stocker R. Dietary supplementation with coenzyme Q10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low-density lipoprotein to the initiation of lipid peroxidation. Biochimica et Biophysica Acta 1992;1126(3):247-54.
63. Morisco C, Trimarco B, Condorelli M. Effect of coenzyme Q10 therapy in patients with congestive heart failure: a long-term, multicentre randomised study. The Clinical Investigator 1993;71(8 Suppl):S134-6.
64. National Health Service. Atherosclerosis. 2010. http://www.nhs.uk/conditions/Atherosclerosis/Pages/Introduction.aspx#commentCountLink (accessed April 2012).
65. Niklowitz P, Sonnenschein A, Janetzky B, Andler W, Menke T. Enrichment of coenzyme Q10 in plasma and blood cells: defense against oxidative damage. International Journal of Biological Sciences 2007;3(4):257-62.
66. Nüesch E, Trelle S, Reichenbach S, Rutjes AW, Tschannen B, Altman DG, et al. Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study. BMJ 2010;341:c3515.
67. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
68. Rosenfeldt F, Hilton D, Pepe S, Krum H. Systematic review of effect of coenzyme Q10 in physical exercise, hypertension and heart failure. Biofactors 2003;18(1-4):91-100.
69. Rosenfeldt FL, Haas SJ, Krum H, Hadj A, Ng K, Leong J-Y, et al. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. Journal of Human Hypertension 2007;21:297-306.
70. Sander S, Coleman CI, Patel AA, Kluger J, White CM. The impact of coenzyme Q10 on systolic function in patients with chronic heart failure. Journal of Cardiac Failure 2006;12(6):464-72.
71. Schaars CF, Stalenhoef AF. Effects of ubiquinone (coenzyme Q10) on myopathy in statin users. Current Opinion in Lipidology 2008;19:553-7.
72. Shekelle P, Morton S, Hardy ML. Effect of supplemental antioxidants vitamin C, vitamin E, and coenzyme Q10 for the prevention and treatment of cardiovascular disease. Evidence Report/Technology Assessment (Summary) 2003;83:1-3.
73. Siri-Tarino P, Sun Q, Hu F, Krauss R. Saturated fat, carbohydrate, and cardiovascular disease. American Journal of Clinical Nutrition 2010;91:502-9.
74. Soja AM, Mortensen SA. Treatment of congestive heart failure with coenzyme Q10 illuminated by meta-analyses of clinical trials. Molecular Aspects of Medicine 1997;18 Suppl:S159-68.
75. Sterne JA, Gavaghan D, Egger M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. Journal of Clinical Epidemiology 2000;53:1119-29.
76. Sterne JA, Egger M, Smith GD. Systematic reviews in health care: investigating and dealing with publication and other biases in meta analysis. BMJ 2001;323:101-5.
77. Sterne JAC, Egger M, Moher D. Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
78. Turunen M, Wehlin L, Sjoberg M, Lundahl J, Dallner G, Brismar K, et al. Beta2-Integrin and lipid modifications indicate a non-antioxidant mechanism for the anti-atherogenic effect of dietary coenzyme Q10. Biochemical and Biophysical Research Communications 2002;296:255-60.
79. van Dalen EC, Caron HN, Dickinson HO, Kremer LCM. Cardioprotective interventions for cancer patients receiving anthracyclines. Cochrane Database of Systematic Reviews 2011, Issue 6. [DOI: 10.1002/14651858.CD003917.pub4]
80. World Health Organization. The World Health Report 2003: Shaping the Future. http://www.who.int/whr/2003/en/(accessed April 2012).
81. World Health Organization. Cardiovascular diseases (CVDs). Fact Sheet Number 317. September 2012. http://www.who.int/mediacentre/factsheets/fs317/en/index.html (accessed April 2012).
82. Joint WHO/FAO Expert Consultation. Diet, nutrition and the prevention of chronic diseases: report of a joint WHO/FAO expert consultation. 2002. WHO technical report series; 916. http://www.who.int/dietphysicalactivity/publications/trs916/en/(accessed April 2012).